Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6834972 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL15101930 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL432664 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL432665 | 0.88 | ALDH1A1 (0.39) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL7748846 | 0.82 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL1723753 | 0.80 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL27978258 | 0.80 | ALDH1A1 (0.33) | ALDH1A1TSHR | |
| SCHEMBL10500043 | 0.78 | ALOX15 (0.35) | ALDH1A1TSHR | |
| SCHEMBL29272040 | 0.78 | HSD17B10 (0.50) | ALDH1A1TSHRHSD17B10TDP1 | |
| SCHEMBL2383130 | 0.78 | ALOX15 (0.35) | ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-09-25 | — | — | US | disclosed |
| EP-4577517-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | disclosed |
| EP-4577516-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2025-07-02 | — | — | EP | disclosed |
| CN-119744258-A | Process for the preparation of 4-hydroxy-2-methylene-butyraldehyde, 4-hydroxy-2-methyl-but-2-enal and their esters | 巴斯夫欧洲公司 | 2025-04-01 | — | — | CN | disclosed |
| CN-119744259-A | Process for the preparation of 4-hydroxy-2-methylene-butyraldehyde, 4-hydroxy-2-methyl-but-2-enal and their esters | 巴斯夫欧洲公司 | 2025-04-01 | — | — | CN | disclosed |
| WO-2024042131-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024042132-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | BASF SE (DE) | 2024-02-29 | — | — | WO | disclosed |
| CN-103201250-A | Novel carboxylic acid ester compound and production therefor, and perfume composition thereof | MITSUBISHI GAS CHEMICAL CO | 2013-07-10 | — | — | CN | disclosed |
| CN-101213280-B | Perfume composition | KAO CORP | 2011-05-18 | — | — | CN | disclosed |
| CN-101213280-A | Perfume composition | KAO CORP (JP) | 2008-07-02 | — | — | CN | disclosed |
| CN-1562998-A | Method for synthesizing compound in condensed carbonyl group | BAIHUA PERFUME CO LTD GUANGZHO (CN) | 2005-01-12 | — | — | CN | disclosed |
| CN-1184221-C | New quinaldinic acid derivative with 7-(7-aminomethyl-5-azaspiro [2,4] heplane) substituent and its preparation method | INST OF MEDICINAL BIOLOG TECHN (CN) | 2005-01-12 | — | — | CN | disclosed |
| CN-1535284-A | Method for producing polymer compositions, polymer compositions obtained by using this method, and use thereof | — | 2004-10-06 | — | — | CN | disclosed |
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | SAGAMI CHEMICAL RESEARCH CENTER (JP) | 2004-06-03 | — | — | US | disclosed |
| EP-1352907-A1 | PROCESSES FOR PREPARING CALANOLIDE A AND INTERMEDIATES THEREOF | KURARAY CO., LTD. (JP) | 2003-10-15 | — | — | EP | disclosed |
| CN-1400209-A | New quinaldinic acid derivative with 7-(7-aminomethyl-5-azaspiro [2,4] heplane) substituent and its preparation method | INST OF MEDICINAL BIOLOG TECHN (CN) | 2003-03-05 | — | — | CN | disclosed |
| US-20030032736-A1 | Acrylic adhesive compositions containing ketonyl (meth)acrylate | KNEAFSEY BRENDAN J (IE) | 2003-02-13 | — | — | US | disclosed |
| WO-2001051576-A1 | ACRYLIC ADHESIVE COMPOSITIONS CONTAINING KETONYL (METH)ACRYLATE | LOCTITE (R & D) LIMITED (IE) | 2001-07-19 | — | — | WO | disclosed |
| US-5800907-A | Method of producing lens method of fabricating article with lens articles with lens resin composition for forming defining lines and lens-forming resin composition | GRAPAC JAPAN CO., INC. (JP) | 1998-09-01 | — | — | US | disclosed |
| US-4009202-A | 2(OR 3)-METHYL-1-ACETOXY-4-ALKOXY (OR PHENOXY)-1,3-BUTADIENES | BADISCHE ANILIN- & SODA-FABRIK AKTIENGESELLSCHAFT (DT) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040106808-A1 | Processes for preparing calanolide a and intermediates thereof | CALR, CYP51A1, CYP4A11 | ALDH1A1 1043/4885TSHR 3981/4885HSD17B10 279/4885 |
| US-20250296906-A1 | METHOD FOR PREPARING 4-HYDROXY-2-METHYLENE-BUTANAL, 4-HYDROXY-2-METHYL-BUT-2-ENAL AND ESTERS THEREOF | ALDH1A2, ADH4, RBP4 | ALDH1A1 21/4885TSHR 3564/4885HSD17B10 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.